جست‌وجوی استاد و پژوهشگر

• Neuropsychology
• Pediatric Neuropsychology
• Child Development
• +۵ مورد دیگر

Sharon Helene O'Neil, PhD, serves as an Associate Professor of Clinical Neurology and Pediatrics at the University of Southern California's Keck School of Medicine and directs the Neuropsychology Core at Children's Hospital Los Angeles (CHLA). Board certified in clinical neuropsychology (ABPP-CN) and pediatric neuropsychology (ABPdN), she integrates clinical practice with research on pediatric neurological conditions. Her research program investigates neuropsychological sequelae across multiple pediatric populations, with primary emphases on brain cancer survivors, preterm infants, congenital heart disease patients, autism spectrum disorders, and sickle/non-sickle anemia syndromes. She employs advanced neuroimaging techniques including diffusion tensor imaging and functional MRI to correlate structural brain changes with cognitive outcomes, particularly focusing on white matter integrity and neurodevelopmental trajectories in high-risk pediatric cohorts. Analysis of her 15 most recent publications reveals consistent methodological rigor across multi-institutional studies, with growing emphasis on hematological conditions like sickle cell disease and neuro-oncology applications. Her work demonstrates strong translational focus, bridging neuroimaging biomarkers with clinically relevant neuropsychological assessments to inform treatment protocols for vulnerable pediatric populations. As Director of CHLA's Neuropsychology Core, Dr. O'Neil oversees a multidisciplinary team conducting both clinical evaluations and research initiatives. She actively trains doctoral students in neuropsychological assessment methodologies, emphasizing evidence-based practice for children with complex medical conditions, though specific grant funding details and named trainees are not documented in available sources.

Gregory Maioمشاهده پروفایل

استاد

• Social Psychology
• Attitudes and Attitude Change
• Values in Relationships
• +۳ مورد دیگر

Gregory Maio is a Professor in the Department of Psychology at the University of Bath, affiliated with the Bath Institute for the Augmented Human. He holds a PhD in Psychology from Western University and has held multiple external roles with organizations like the Economic and Social Research Council and the Netherlands Organisation for Scientific Research. Education: Doctor of Philosophy (Psychology), Western University (1993–1997) Master of Arts (Psychology), Western University (1991–1993) Bachelor of Science (Psychology), York University (1987–1991) Research Interests: Dr. Maio focuses on social psychology topics including social values, intellectual humility in debates, values in close relationships, and attitudes toward children. His work contributes to UN Sustainable Development Goals related to education. Key contributions include two books: The Psychology of Values and The Psychology of Attitudes and Attitude Change (3rd ed.). Recent Research Trends: His articles explore themes like group similarities, anti-immigrant prejudice, protest attitudes, and neuro-functional bases of persuasion. These studies emphasize individual differences, cognitive processes, and societal impacts. Collaborations span institutions in the UK and beyond. Grants & Projects: Lead Investigator on projects funded by the Economic and Social Research Council (e.g., mental representations of children, changing attitudes in public discourse). Panel roles for grant assessments and security threat mitigation initiatives. Labs/Teams: Active in interdisciplinary research through the Bath Institute for the Augmented Human, focusing on psychological and neuroscientific applications in social contexts.

Vance Zemonمشاهده پروفایل

استاد

• Visual Neuroscience
• Evoked Brain Potentials
• Psychophysics
• +۵ مورد دیگر

Dr. Vance Zemon is a Professor of Psychology at the Ferkauf Graduate School of Psychology, part of Yeshiva University's Albert Einstein College of Medicine campus. He holds adjunct faculty roles and serves as a Visiting Scientist at the Nathan Kline Institute for Psychiatric Research. His research focuses on visual neuroscience, electrophysiological measurements (e.g., visual evoked potentials), and clinical applications in psychiatric, neurological, and ophthalmic disorders. He teaches systems neuroscience, physiological psychology, and statistics. Awards include the Labe Scheinberg Award and Fellow status in the Association for Research in Vision and Ophthalmology (ARVO). His work integrates psychophysical, neuroimaging, and clinical methodologies to address perceptual and cognitive impairments in conditions like schizophrenia and multiple sclerosis. Education: B.S. in Physics, Clarkson College of Technology (1973) M.A. & Ph.D. in Experimental Psychology, Northeastern University (1976, 1979) NIH Postdoctoral Fellowship at Rockefeller University (1979–1982) Research Interests: Visual perception and neural processing Electrophysiological biomarkers (e.g., VEPs) Clinical applications in schizophrenia, multiple sclerosis, and autism spectrum disorder Neurorehabilitation and visual remediation Awards & Roles: Scientific Advisory Board Member, Blythedale Children’s Hospital Editorial Board Member, International Journal of Neuroscience Recipient of ARVO’s Program Committee Leadership Teaching: Courses include Systems Neuroscience, Physiological Psychology, and advanced statistics for graduate students. Labs & Collaborations: Engages with the Nathan Kline Institute and Blythedale Children’s Hospital, focusing on translational research linking electrophysiological findings to clinical outcomes.

Kjetil Wessel Andressenمشاهده پروفایل

دانشیار

• Pharmacology
• Heart Failure
• Cellular Signal Transduction
• +۷ مورد دیگر

Kjetil Wessel Andressen is an Associate Professor in the Department of Pharmacology at the Faculty of Medicine, University of Oslo. He is actively involved in research on heart failure, cellular signal transduction, and the development of new pharmacological targets for HFrEF and HFpEF. His work integrates molecular pharmacology, biosensor technology, and cardiac physiology. Andressen holds a Cand. Pharm. (2002) and a PhD (2008), both from the University of Oslo. His research focuses on GPCR signaling, cAMP and cGMP dynamics, and compartmentalized signaling in cardiomyocytes, with an emphasis on natriuretic peptides and phosphodiesterase regulation. He has developed and applied FRET-based biosensors to visualize real-time signaling events. His recent publications reveal a strong trend in understanding spatial organization of cyclic nucleotide signaling in cardiac cells, particularly in disease states. His work bridges molecular mechanisms with therapeutic implications in heart failure and receptor pharmacology. Member, Norwegian Society for Pharmacology and Toxicology Leader of Section of Pharmacology (2012–2016) Scientific Awards: No specific awards mentioned in the provided text. He advises no listed students but collaborates extensively with national and international researchers, including those from Oxford, Hamburg, Baylor College of Medicine, and Karolinska Institutet. He is involved in the Center for Heart Failure Research at Oslo University Hospital (OUS) and leads research groups on compartmentation of cardiac signaling and receptor pharmacology.

• Neurological Physiotherapy
• Stroke Rehabilitation
• Multiple Sclerosis
• +۶ مورد دیگر

Dr. James McLoughlin is an Associate Professor at Flinders University and Director of Advanced Neuro Rehab in Adelaide. He holds a PhD in Neuroscience and combines clinical practice with academic roles in neurological physiotherapy education. His expertise spans stroke rehabilitation, degenerative neurological disorders, and motor control, with a focus on advancing clinical practice through education and research. Affiliations: Flinders University (Associate Professor), Advanced Neuro Rehab (Director) Education: PhD (UNSW), Master of Clinical Neuroscience (Distinction, University College London), Bachelor of Physiotherapy (UniSA) Research interests include neurorehabilitation, vestibular dysfunction, and the application of evidence-based practices in clinical settings. Collaborations include Queen Square’s Sobell Department of Motor Neuroscience and Neuroscience Research Australia. He has developed the Neurological Physiotherapy Master’s program at Flinders University and delivered over 50 international short courses. Key articles focus on stroke recovery, concussion management, and dementia care. Awards and recognitions include editorial roles and committee memberships with the Australian Physiotherapy Association.

• MRI
• Brain Imaging (EEG, MRI)
• Neuroscience
• +۴ مورد دیگر

Franceschiello Benedetta is an Associate Professor at HES-SO Valais-Wallis School of Engineering, specializing in Technical and IT disciplines. She holds a PhD in Mathematical Neuroscience from Université Pierre et Marie Curie (Paris). Her work bridges applied mathematics, computational neuroscience, and neuroimaging, with a focus on visual perception modeling, MRI techniques, and neural dynamics. Teaching: Linear Algebra courses across multiple engineering bachelor programs Expertise: Combines mathematical modeling with neuroscientific applications to study optical illusions, brain connectivity, and ophthalmic diagnostics Key Affiliations: ISMRM, Organization for Human Brain Mapping (OHBM), Association for Research in Vision and Ophthalmology (ARVO) Research Interests: Computational modeling of visual cortex mechanisms underlying geometric optical illusions Development of MRI-based methods for eye structure segmentation and axial length estimation Analysis of brain network reliability through standardized MRI protocols Optimization techniques for medical imaging reconstruction (e.g., weighted LASSO problems) Recent Work Trends: Focus on integrating psychophysical experiments with computational models to elucidate perceptual mechanisms, emphasizing synergistic interactions between physical stimulus parameters. Active in advancing MRI applications for both clinical diagnostics and fundamental neuroscience research.

Julien Licchesiمشاهده پروفایل

مدرس ارشد

• Ubiquitin Biology
• Protein Degradation
• Targeted Protein Degradation
• +۷ مورد دیگر

Dr. Julien Licchesi is a Senior Lecturer in the Department of Life Sciences at the University of Bath. His research focuses on ubiquitin biology and protein degradation mechanisms, with applications in neurodegenerative diseases and cancer therapeutics. Dr. Licchesi's research interests center on how ubiquitin regulates protein fate and function. His lab uses biochemical, structural, and cell biology techniques to study E3 ubiquitin ligases (particularly HECTD1) and deubiquitylases (particularly TRABID). His work has identified unique ubiquitin chain types (K29/K48 branched chains) and the TRABID-HECTD1 regulatory pair. His research has significant implications for Targeted Protein Degradation (TPD) therapeutics, which aim to address the 'undruggable proteome' comprising 85% of proteins not targetable by conventional drugs. Analysis of Dr. Licchesi's recent publications reveals a strong focus on HECTD1's role in cell proliferation, mitosis, and cancer (particularly glioblastoma), as well as its regulation by caspases during apoptosis. His work bridges fundamental ubiquitin biology with therapeutic applications, especially in neurodegenerative diseases and cancer. Dr. Licchesi has supervised 5 PhD students, with alumni working as Patent Attorneys, Manufacturing Scientists at BioRad Laboratories, or Lecturers at Kuwait University. He currently serves as Principal Investigator for multiple research projects including 'Proteostatic regulation of Glioblastoma stemness' (MRC-funded, 2023-2027) and 'New approach to destroy disease-causing proteins in Alzheimer's disease' (Alzheimer's Research UK-funded). His laboratory actively collaborates with institutions including Victoria University (Canada), EMBL Hamburg, University of Bristol, and Cardiff University. Current projects in his lab include structure-function studies of E3 ubiquitin ligases, developing new TPD modalities, exploring HECTD1 in cell signaling, and identifying new ubiquitin enzymes in pathogenic bacteria.

• Chronic Rhinosinusitis
• Olfactory Dysfunction
• Vitamin D Metabolism
• +۵ مورد دیگر

Jennifer K. Mulligan is an Associate Professor in the Department of Otolaryngology – Head & Neck Surgery at the University of Florida. She holds multiple leadership roles including Vice Chair for Research, Co-Director of the UF Health Smell Disorders Program, and Director of Resident Research Education. Her academic work focuses on the immunopathogenesis of chronic rhinosinusitis (CRS) and olfactory dysfunction, with a particular interest in vitamin D metabolism, complement system regulation, and epithelial cell biology. Her research employs experimental models and clinical studies to investigate mechanisms underlying sinonasal inflammation and olfactory impairment. Notable contributions include elucidating roles of vitamin D3 in modulating immune responses and epithelial function, and developing biomarker-based endotyping strategies for CRS subtypes. She has pioneered nasal mucus proteomics and olfactory cleft analysis to identify novel therapeutic targets. Dr. Mulligan's grant portfolio includes NIH-funded projects on vitamin D modulation of CRS inflammation, immune responses to SARS-CoV-2 in upper airways, and biologic therapies for nasal polyposis. She leads clinical trials evaluating treatments like dupilumab for smell recovery. Over 100 peer-reviewed publications span immunology, otolaryngology, and translational research methodologies. Her teaching activities include instructing the GMS6847 course on translational research principles. She mentors residents and fellows in surgical research through structured educational programs. Active collaborations involve immunologists, bioengineers, and clinical researchers across multiple institutions.

• Acute Lymphoblastic Leukemia
• Pediatric Brain Tumors
• Genetic Heterogeneity
• +۵ مورد دیگر

Stephen E. Sallan, MD , is a Professor of Pediatrics at Harvard Medical School and a Physician at Dana-Farber Cancer Institute and Children's Hospital . His career spans over five decades in pediatric hematology/oncology , with a focus on acute lymphoblastic leukemia (ALL) and pediatric brain tumors . Education : MD, Wayne State University School of Medicine (1967) Residencies : Boston Floating Hospital (1968), Children's Hospital of Philadelphia (1969), Hospital for Sick Children, London (1970) Fellowship : Pediatric Oncology, Children's Hospital/DFCI (1972) Leadership Roles : Chief of Staff (1995), Chairman of Medical Staff Executive Committee (1995), Chief of Staff Emeritus (2012) Dr. Sallan's research integrates genetic heterogeneity , disease recurrence , and drug resistance in ALL, with efforts to develop targeted therapies like tumor vaccines and antiangiogenesis agents. His work addresses long-term treatment toxicities (cardiac, skeletal, neurocognitive), particularly in survivors of childhood cancers. His 15 most recent publications (2024–2018) demonstrate ongoing engagement with pharmacogenomics, thrombosis risk models, dietary interventions, and molecular markers in brain tumors. Key subfields include TRK-C in medulloblastoma , asparaginase complications , and DFCI ALL Consortium Protocols . Scientific Awards : Distinguished Alumni Award, Wayne State University School of Medicine (1997) James Carreras Prize for International Pediatrician of the Year (1987) As a leader in pediatric leukemia research , Dr. Sallan has shaped treatment protocols that minimize late effects while improving survival. He collaborates with multidisciplinary teams in neuro-oncology and pharmacogenomics, maintaining active roles in clinical trials and laboratory investigations.

• Developmental Psychology
• Neuroscience
• Child Development
• +۷ مورد دیگر

Dr. Sonja de Zwarte is an Assistant Professor in the Department of Psychology within the Faculty of Social and Behavioral Sciences at Utrecht University. Her office is located in the Martinus J. Langeveld building at Heidelberglaan 1 in Utrecht. She maintains an active research program focusing on developmental psychology and neuroscience, with particular emphasis on early childhood development and brain imaging. Her research interests span multiple interconnected domains including the critical first 1001 days of child development, prenatal brain development, schizophrenia and bipolar disorder research, genetic risk factors, and the application of artificial intelligence in behavioral analysis. Her work often involves large-scale collaborative efforts through international consortia such as ENIGMA (Enhancing Neuro Imaging Genetics Through Meta Analysis), which enables powerful analyses of brain structure and function across thousands of participants worldwide. Dr. de Zwarte's publication record demonstrates consistent productivity with numerous high-impact publications in top neuroscience and psychiatry journals. Her recent work shows a clear trajectory integrating advanced neuroimaging techniques with genetic analysis to understand developmental pathways in both typical and at-risk populations. She has made significant contributions to understanding how genetic risk factors manifest in brain structure and cognitive function, particularly in relation to schizophrenia and bipolar disorder. Her methodological expertise spans both traditional neuroimaging analysis and cutting-edge applications of artificial intelligence to behavioral data, as evidenced by her recent work on automated segmentation of fetal brain structures using deep learning and automated analysis of parent-child interactions. This interdisciplinary approach positions her work at the intersection of developmental psychology, clinical neuroscience, and computational methods.

• Structural Biology
• Chemical Biology
• Cancer Therapeutics
• +۵ مورد دیگر

Alex Bullock is Professor of Structural and Chemical Biology at the University of Oxford, where he leads the Growth Factor Signalling and Ubiquitination research group. His multidisciplinary work bridges structural biology, chemical biology, and therapeutic development for cancer and rare diseases. He holds a PhD from the University of Cambridge and completed postdoctoral work at the University of Washington and Oxford, supported by a Wellcome Fellowship. His research focuses on: Disease-causing mutations in kinases (e.g., ALK2 in fibrodysplasia ossificans progressiva and brain tumors) E3 ubiquitin ligase neofunction (e.g., KBTBD4 in medulloblastoma) Development of PROTACs for targeted protein degradation Small-molecule inhibitors for undruggable targets He leads a phase 2 clinical trial for the ALK2 inhibitor saracatinib and collaborates globally with institutions including Stanford, Harvard, and the University of Edinburgh. His publications emphasize kinase inhibition, ubiquitin pathways, and structure-guided drug design, with recent work on KEAP1-Nrf2 inhibitors, E3 ligases, and chemical probes for kinases like CDKL5/GSK3. Awards include the Wellcome Fellowship . He engages with disease foundations (FOP Friends, Brain Tumour Charity) and public outreach.

Michael S. Cohenمشاهده پروفایل

دانشیار

• Chemical Biology
• Molecular Design
• NAD+ Regulation
• +۳ مورد دیگر

Michael S. Cohen is an Associate Professor in the Department of Biochemistry and Molecular Biology at Oregon Health & Science University (OHSU) School of Medicine. His research program integrates chemical biology and molecular design to develop novel tools for probing NAD+ regulation and ADP-ribosylation in cellular systems. His educational background includes: B.S. from University of California, Irvine (2000) Ph.D. from University of California, San Francisco (2006) LSRF Postdoctoral Fellowship at Weill Cornell Medical College (2006-2011) Dr. Cohen's laboratory focuses on two interconnected research pillars: (1) elucidating novel roles for NAD+ metabolism in cellular physiology, and (2) deciphering the biological functions of ADP-ribosylation—a post-translational modification catalyzed by PARP enzymes. His team pioneered orthogonal NAD+ analogue-enzyme pairs, selective PARP inhibitors, and real-time NAD+ biosensors that overcome limitations of conventional methods. These chemical tools enable precise manipulation and monitoring of NAD+-dependent processes in living cells. Analysis of his 15 most recent publications (2020-2025) reveals a strategic expansion from fundamental mechanism discovery toward translational applications. Key themes include PARP-mediated immune regulation (e.g., PARP7 in interferon signaling and autoimmunity), cancer immunotherapy enhancement (via PARP11 modulation of regulatory T cells), and neuro-cardiac repair mechanisms. His work bridges chemical biology, immunology, and regenerative medicine through innovative molecular engineering. His scientific recognition includes: Pew Biomedical Scholar (2015) Richard T. Jones New Investigator Award (2016) ICBS Young Chemical Biologist Award (2018) Dr. Cohen mentors graduate students and postdoctoral fellows in chemical biology techniques, with research supported by NIH and foundation grants. His laboratory maintains active collaborations with OHSU clinicians investigating applications in autoimmunity, viral pathogenesis, and cardiac injury models. The Cohen Lab operates within OHSU's collaborative research ecosystem, utilizing core facilities for chemical proteomics and live-cell imaging to translate basic discoveries into therapeutic strategies for NAD+-related pathologies.

Jochen Klumppمشاهده پروفایل

مدرس ارشد

• Bacteriology
• Virology
• Microbiology
• +۴ مورد دیگر

PD Dr. Jochen Klumpp is a Senior Lecturer in the Department of Health Sciences and Technology (D-HEST) at ETH Zurich. His research focuses on bacteriophage biology, bacterial pathogenesis, and antimicrobial strategies. He leads studies on phage-host interactions, phage-based diagnostics, and phage therapy applications, particularly targeting pathogens like Campylobacter, Salmonella, and Mycobacterium tuberculosis. Key research areas include phage resistance mechanisms, genomic analysis of bacterial pathogens, and development of broad-spectrum phage cocktails. His work spans food safety, clinical microbiology, and evolutionary virology. Recent studies emphasize engineering phages for rapid pathogen detection in clinical samples and exploring phage diversity in environmental and clinical settings. Publications highlight innovations in phage taxonomy, CRISPR-Cas9 systems in bacteria, and structural biology of phage-tail components. Collaborations with global institutions, including Thailand and Kenya, underscore his commitment to addressing global health challenges through phage research. Awards: None explicitly listed. Advising/Grants: No student names or grant details provided. Research is supported through institutional and collaborative funding. Labs/Teams: Part of D-HEST's microbiology and biotechnology research groups, focusing on applied and fundamental phage research.

Fatemeh Vafaeeمشاهده پروفایل

دانشیار

• Artificial Intelligence
• Machine Learning
• Systems Biology
• +۵ مورد دیگر

Associate Professor Fatemeh Vafaee is a leading researcher at the University of New South Wales (UNSW) , holding appointments as Associate Professor in the School of Biotechnology and Biomolecular Sciences (BABS) and Deputy Director (Science) of the UNSW AI Institute . She previously served as Deputy Director of the UNSW Data Science Hub (uDASH) and has held academic positions at the University of Toronto and the University of Sydney. PhD in Artificial Intelligence from University of Illinois at Chicago Postdoctoral Fellowships at University of Toronto and University of Sydney Founded the AI-Enhanced Biomedicine Laboratory in 2017 Her research focuses on deploying advanced AI techniques to address biomedical challenges through: Biomarker Discovery for cancer and neurodegenerative diseases Single-Cell Multi-Omics data integration and analysis Computational Drug Repositioning and network pharmacology Multi-Omics Data Fusion and temporal network modeling Recent publications demonstrate expertise in liquid biopsy development , single-cell imaging , and AI-driven cancer diagnostics . Her methodological contributions include novel deep learning architectures for omics data analysis and graph neural networks for drug synergy prediction. Scientific accolades include: Winner, Women in AI Asia-Pacific Health Award (2023) Runner-Up, WAI-APAC Innovator of the Year (2023) Top 10 Women in AI in Asia-Pacific (2023) Australian Bioinformatics and Computational Biology Society Research Excellence Award (2023) She supervises PhD candidates across computational biomedicine and AI in healthcare , with significant grant achievements exceeding $17M in competitive funding, including schemes from ARC Discovery , NHMRC , and Medical Research Future Fund .

Manuela Zucknickمشاهده پروفایل

استاد

• Statistical learning for translational cancer research
• Personalized cancer therapies
• Multi-omics data integration
• +۷ مورد دیگر

Manuela Zucknick is Professor and Director of the Oslo Centre for Biostatistics and Epidemiology at the University of Oslo's Faculty of Medicine, Department of Biostatistics. Her research integrates statistical learning with translational cancer research to advance personalized medicine through multi-omics data integration. PhD Biostatistics, Imperial College London (2008) MSc Bioinformatics, Imperial College London (2004) Diplom Statistik, University of Dortmund (2003) Her research focuses on Bayesian methods for integrating heterogeneous data sources in cancer research, particularly for drug response prediction in pharmacogenomic screens and patient prognosis. She develops structured high-dimensional regression models for 'large p, small n' problems in molecular medicine, with emphasis on incorporating prior biological knowledge into risk prediction frameworks. Her work bridges statistical methodology with clinical applications in personalized cancer therapies. Her recent publications demonstrate consistent contributions to multi-omics integration and survival modeling across diverse clinical contexts including cancer, pregnancy complications, and rheumatoid arthritis. The research shows strong methodological innovation in handling high-dimensional biological data while maintaining clinical relevance. Through the Oslo Centre for Biostatistics and Epidemiology, she leads collaborative projects spanning oncology, obstetrics, and rheumatology. Her work frequently involves designing statistical frameworks for pharmacogenomic screens and developing tools for biomarker discovery in complex disease settings.